Loading…

Obesity-hypertension: the effects on cardiovascular and renal systems

Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retentio...

Full description

Saved in:
Bibliographic Details
Published in:American Journal of Hypertension 2000-12, Vol.13 (12), p.1308-1314
Main Authors: Zhang, Rubin, Reisin, Efrain
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083
cites cdi_FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083
container_end_page 1314
container_issue 12
container_start_page 1308
container_title American Journal of Hypertension
container_volume 13
creator Zhang, Rubin
Reisin, Efrain
description Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retention with concomitant expanded cardiopulmonary volume and increased cardiac output. The cellular metabolism of cations may be altered in obesity and may lead to changes in vascular responsiveness and increased vascular resistance. These changes lead to structural adaptations in the heart characterized by concentric–eccentric left ventricular hypertrophy. The hypertrophic condition provides the basis for the development of congestive heart failure and cardiac arrhythmias that may explain the higher rates of cardiac sudden death in those patients. In the kidneys, obesity hypertension may initiate a derangement of renal function. The increased deposit of interstitial cells and of extracellular matrix between the tubules induces higher interstitial hydrostatic pressure and tubular sodium reabsorption. The consequent increase in renal flow and glomerular filtration enhances albuminuria excretion and the susceptibility to the development of renal damage. In summary, the hemodynamic and structural adaptations related to obesity hypertension is the cause of greater risk for adverse cardiovascular and renal events.
doi_str_mv 10.1016/S0895-7061(00)01254-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72514830</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1016/S0895-7061(00)01254-1</oup_id><els_id>S0895706100012541</els_id><sourcerecordid>2713043551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083</originalsourceid><addsrcrecordid>eNqFkVFr1TAUx4Mo7m76EZSCMPQh86RpktYXkW3eCdMJUxBfQpqessze5i5ph_fbm66XqxPBp7z8_v9z8juEPGNwxIDJ15dQVoIqkOwlwCtguSgoe0AWrFQVZRWIh2SxQ_bIfozXAFBIyR6TPcYYB6Xkgpxe1BjdsKFXmzWGAfvofP8mG64ww7ZFO8TM95k1oXH-1kQ7diZkpm-ygL3psriJA67iE_KoNV3Ep9v3gHx9f_rl-IyeXyw_HL87p1ZUYqAtV3XdcMklGitRmEIBcFOJqgAQqlamsVKJqmYW6rZIdCvEtAaayjZQ8gNyOPeug78ZMQ565aLFrjM9-jFqlQtWlBwS-OIv8NqPIW0cNYNcSshVWSRKzJQNPsaArV4HtzJhkyA9WdZ3lvWkUAPoO8uapdzzbftYr7D5ndpq_WN8Uma6NpjeurjjSlayfKqBmfLj-t-T6b3JdIrQOeKS95-7kAk_tFRcCX327bsuP39c8k_LS32S-Lczj-kqtw6DjtZhb7FxIR1XN97956-_AIUbtTs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1026602784</pqid></control><display><type>article</type><title>Obesity-hypertension: the effects on cardiovascular and renal systems</title><source>Oxford Journals Online</source><creator>Zhang, Rubin ; Reisin, Efrain</creator><creatorcontrib>Zhang, Rubin ; Reisin, Efrain</creatorcontrib><description>Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retention with concomitant expanded cardiopulmonary volume and increased cardiac output. The cellular metabolism of cations may be altered in obesity and may lead to changes in vascular responsiveness and increased vascular resistance. These changes lead to structural adaptations in the heart characterized by concentric–eccentric left ventricular hypertrophy. The hypertrophic condition provides the basis for the development of congestive heart failure and cardiac arrhythmias that may explain the higher rates of cardiac sudden death in those patients. In the kidneys, obesity hypertension may initiate a derangement of renal function. The increased deposit of interstitial cells and of extracellular matrix between the tubules induces higher interstitial hydrostatic pressure and tubular sodium reabsorption. The consequent increase in renal flow and glomerular filtration enhances albuminuria excretion and the susceptibility to the development of renal damage. In summary, the hemodynamic and structural adaptations related to obesity hypertension is the cause of greater risk for adverse cardiovascular and renal events.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1879-1905</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1016/S0895-7061(00)01254-1</identifier><identifier>PMID: 11130776</identifier><identifier>CODEN: AJHYE6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; blood pressure ; cardiovascular disease ; Cardiovascular System - drug effects ; Cardiovascular System - physiopathology ; Humans ; Hypertension - complications ; Hypertension - physiopathology ; Kidney - drug effects ; Kidney - pathology ; Kidney - physiopathology ; Leptin - pharmacology ; Leptin - physiology ; Medical sciences ; Metabolic diseases ; Natriuretic Agents - physiology ; Obesity ; Obesity - complications ; Obesity - pathology ; Obesity - physiopathology ; renal hemodynamics</subject><ispartof>American Journal of Hypertension, 2000-12, Vol.13 (12), p.1308-1314</ispartof><rights>2000 American Journal of Hypertension, Ltd.</rights><rights>American Journal of Hypertension, Ltd. © 2000 by the American Journal of Hypertension, Ltd. 2000</rights><rights>2001 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Dec 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083</citedby><cites>FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>313,314,776,780,788,27896,27898,27899</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=818121$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11130776$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Rubin</creatorcontrib><creatorcontrib>Reisin, Efrain</creatorcontrib><title>Obesity-hypertension: the effects on cardiovascular and renal systems</title><title>American Journal of Hypertension</title><addtitle>AJH</addtitle><description>Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retention with concomitant expanded cardiopulmonary volume and increased cardiac output. The cellular metabolism of cations may be altered in obesity and may lead to changes in vascular responsiveness and increased vascular resistance. These changes lead to structural adaptations in the heart characterized by concentric–eccentric left ventricular hypertrophy. The hypertrophic condition provides the basis for the development of congestive heart failure and cardiac arrhythmias that may explain the higher rates of cardiac sudden death in those patients. In the kidneys, obesity hypertension may initiate a derangement of renal function. The increased deposit of interstitial cells and of extracellular matrix between the tubules induces higher interstitial hydrostatic pressure and tubular sodium reabsorption. The consequent increase in renal flow and glomerular filtration enhances albuminuria excretion and the susceptibility to the development of renal damage. In summary, the hemodynamic and structural adaptations related to obesity hypertension is the cause of greater risk for adverse cardiovascular and renal events.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>blood pressure</subject><subject>cardiovascular disease</subject><subject>Cardiovascular System - drug effects</subject><subject>Cardiovascular System - physiopathology</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Hypertension - physiopathology</subject><subject>Kidney - drug effects</subject><subject>Kidney - pathology</subject><subject>Kidney - physiopathology</subject><subject>Leptin - pharmacology</subject><subject>Leptin - physiology</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Natriuretic Agents - physiology</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Obesity - pathology</subject><subject>Obesity - physiopathology</subject><subject>renal hemodynamics</subject><issn>0895-7061</issn><issn>1879-1905</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkVFr1TAUx4Mo7m76EZSCMPQh86RpktYXkW3eCdMJUxBfQpqessze5i5ph_fbm66XqxPBp7z8_v9z8juEPGNwxIDJ15dQVoIqkOwlwCtguSgoe0AWrFQVZRWIh2SxQ_bIfozXAFBIyR6TPcYYB6Xkgpxe1BjdsKFXmzWGAfvofP8mG64ww7ZFO8TM95k1oXH-1kQ7diZkpm-ygL3psriJA67iE_KoNV3Ep9v3gHx9f_rl-IyeXyw_HL87p1ZUYqAtV3XdcMklGitRmEIBcFOJqgAQqlamsVKJqmYW6rZIdCvEtAaayjZQ8gNyOPeug78ZMQ565aLFrjM9-jFqlQtWlBwS-OIv8NqPIW0cNYNcSshVWSRKzJQNPsaArV4HtzJhkyA9WdZ3lvWkUAPoO8uapdzzbftYr7D5ndpq_WN8Uma6NpjeurjjSlayfKqBmfLj-t-T6b3JdIrQOeKS95-7kAk_tFRcCX327bsuP39c8k_LS32S-Lczj-kqtw6DjtZhb7FxIR1XN97956-_AIUbtTs</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>Zhang, Rubin</creator><creator>Reisin, Efrain</creator><general>Elsevier Inc</general><general>Oxford University Press</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20001201</creationdate><title>Obesity-hypertension: the effects on cardiovascular and renal systems</title><author>Zhang, Rubin ; Reisin, Efrain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>blood pressure</topic><topic>cardiovascular disease</topic><topic>Cardiovascular System - drug effects</topic><topic>Cardiovascular System - physiopathology</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Hypertension - physiopathology</topic><topic>Kidney - drug effects</topic><topic>Kidney - pathology</topic><topic>Kidney - physiopathology</topic><topic>Leptin - pharmacology</topic><topic>Leptin - physiology</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Natriuretic Agents - physiology</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Obesity - pathology</topic><topic>Obesity - physiopathology</topic><topic>renal hemodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Rubin</creatorcontrib><creatorcontrib>Reisin, Efrain</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>American Journal of Hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Rubin</au><au>Reisin, Efrain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Obesity-hypertension: the effects on cardiovascular and renal systems</atitle><jtitle>American Journal of Hypertension</jtitle><addtitle>AJH</addtitle><date>2000-12-01</date><risdate>2000</risdate><volume>13</volume><issue>12</issue><spage>1308</spage><epage>1314</epage><pages>1308-1314</pages><issn>0895-7061</issn><eissn>1879-1905</eissn><eissn>1941-7225</eissn><coden>AJHYE6</coden><abstract>Longitudinal and cross-sectional studies suggest that a large number of obese patients have a high prevalence of hypertension. This association causes the following changes: insulin and leptin resistance with a suppressed biologic activity of natriuretic peptide, which contributes to sodium retention with concomitant expanded cardiopulmonary volume and increased cardiac output. The cellular metabolism of cations may be altered in obesity and may lead to changes in vascular responsiveness and increased vascular resistance. These changes lead to structural adaptations in the heart characterized by concentric–eccentric left ventricular hypertrophy. The hypertrophic condition provides the basis for the development of congestive heart failure and cardiac arrhythmias that may explain the higher rates of cardiac sudden death in those patients. In the kidneys, obesity hypertension may initiate a derangement of renal function. The increased deposit of interstitial cells and of extracellular matrix between the tubules induces higher interstitial hydrostatic pressure and tubular sodium reabsorption. The consequent increase in renal flow and glomerular filtration enhances albuminuria excretion and the susceptibility to the development of renal damage. In summary, the hemodynamic and structural adaptations related to obesity hypertension is the cause of greater risk for adverse cardiovascular and renal events.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11130776</pmid><doi>10.1016/S0895-7061(00)01254-1</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American Journal of Hypertension, 2000-12, Vol.13 (12), p.1308-1314
issn 0895-7061
1879-1905
1941-7225
language eng
recordid cdi_proquest_miscellaneous_72514830
source Oxford Journals Online
subjects Animals
Biological and medical sciences
blood pressure
cardiovascular disease
Cardiovascular System - drug effects
Cardiovascular System - physiopathology
Humans
Hypertension - complications
Hypertension - physiopathology
Kidney - drug effects
Kidney - pathology
Kidney - physiopathology
Leptin - pharmacology
Leptin - physiology
Medical sciences
Metabolic diseases
Natriuretic Agents - physiology
Obesity
Obesity - complications
Obesity - pathology
Obesity - physiopathology
renal hemodynamics
title Obesity-hypertension: the effects on cardiovascular and renal systems
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-03-03T21%3A08%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Obesity-hypertension:%20the%20effects%20on%20cardiovascular%20and%20renal%20systems&rft.jtitle=American%20Journal%20of%20Hypertension&rft.au=Zhang,%20Rubin&rft.date=2000-12-01&rft.volume=13&rft.issue=12&rft.spage=1308&rft.epage=1314&rft.pages=1308-1314&rft.issn=0895-7061&rft.eissn=1879-1905&rft.coden=AJHYE6&rft_id=info:doi/10.1016/S0895-7061(00)01254-1&rft_dat=%3Cproquest_cross%3E2713043551%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c595t-f37bbd3636eac6e5a47003a95940057b7adc6759b1c0bf437bf55effeea9cd083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1026602784&rft_id=info:pmid/11130776&rft_oup_id=10.1016/S0895-7061(00)01254-1&rfr_iscdi=true